{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:46:00Z","timestamp":1767033960163},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,5,12]],"date-time":"2006-05-12T00:00:00Z","timestamp":1147392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00431-006-0136-x","type":"journal-article","created":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T18:21:53Z","timestamp":1147371713000},"page":"598-604","source":"Crossref","is-referenced-by-count":64,"title":["Development of an optimal lidocaine infusion strategy for neonatal seizures"],"prefix":"10.1007","volume":"165","author":[{"given":"Mirte M.","family":"Malingr\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda G. M.","family":"Van Rooij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carin M. A.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona C.","family":"Toet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa F. F. T.","family":"Ververs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"van Kesteren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,5,12]]},"reference":[{"key":"136_CR1","unstructured":"Beal SL, Boeckman AJ, Sheiner LB (1988\u20131992)NONMEM: User\u2019s guides, University of California at San Francisco, San Francisco"},{"key":"136_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-197803030-00001","volume":"3","author":"NL Benowitz","year":"1978","unstructured":"Benowitz NL, Meister W (1978) Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet 3:177\u2013201","journal-title":"Clin Pharmacokinet"},{"key":"136_CR3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/088307380201700520","volume":"17","author":"I Berger","year":"2002","unstructured":"Berger I, Steinberg A, Schlesinger Y, Seelenfreund M, Schimmel MS (2002) Neonatal mydriasis: intravenous lidocaine adverse reaction. J Child Neurol 17:400\u2013401","journal-title":"J Child Neurol"},{"key":"136_CR4","first-page":"31","volume":"186","author":"J Blumer","year":"1973","unstructured":"Blumer J, Strong JM, Atkinson AJ (1973) The convulsant potency of lidocaine and its N-dealkylated metabolites. J Pharmacol Exp Ther 186:31\u201336","journal-title":"J Pharmacol Exp Ther"},{"key":"136_CR5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-8703(74)90287-7","volume":"88","author":"RG Burney","year":"1974","unstructured":"Burney RG, DiFazio CA, Peach MJ, Petrie KA, Silvester MJ (1974) Anti-arrhythmic effects of lidocaine metabolites. Am Heart J 88:765\u2013769","journal-title":"Am Heart J"},{"key":"136_CR6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2125.1998.t01-1-00768.x","volume":"46","author":"TJ Campbell","year":"1998","unstructured":"Campbell TJ, Williams KM (1998) Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol 46:307\u2013319","journal-title":"Br J Clin Pharmacol"},{"key":"136_CR7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00007691-200006000-00014","volume":"22","author":"JC DeToledo","year":"2000","unstructured":"DeToledo JC (2000) Lidocaine and seizures. Ther Drug Monit 22:320\u2013322","journal-title":"Ther Drug Monit"},{"key":"136_CR8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1023\/A:1016215116835","volume":"12","author":"E Ette","year":"1995","unstructured":"Ette E, Ludden T (1995) Population pharmacokinetic modeling: the importance of informative graphics. Pharm Res 12: 1845\u20131855","journal-title":"Pharm Res"},{"key":"136_CR9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1345\/aph.17304","volume":"32","author":"E Ette","year":"1998","unstructured":"Ette E (1998) Statistical graphics in pharmacokinetics and pharmacodynamics: a tutorial. Ann Pharmacother 32: 818\u2013828","journal-title":"Ann Pharmacother"},{"key":"136_CR10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJM196712072772301","volume":"277","author":"R Gianelly","year":"1967","unstructured":"Gianelly R, von der Groeben JO, Spivack AP, Harrison DC (1967) Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med 277:1215\u20131219","journal-title":"N Engl J Med"},{"key":"136_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1651-2227.1988.tb10602.x","volume":"77","author":"L Hellstr\u00f6m-Westas","year":"1988","unstructured":"Hellstr\u00f6m-Westas L, Westgren U, Ros\u00e9n I, Svenningsen NW (1988) Lidocaine for treatment of severe seizures in newborn infants. I. Clinical effects and cerebral electrical activity monitoring. Acta Paediatr Scand 77:79\u201384","journal-title":"Acta Paediatr Scand"},{"key":"136_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1651-2227.1992.tb12075.x","volume":"81","author":"L Hellstr\u00f6m-Westas","year":"1992","unstructured":"Hellstr\u00f6m-Westas L, Svenningsen NW, Westgren U, Ros\u00e9n I, Lagerstrom PO (1992) Lidocaine for treatment of severe seizures in newborn infants. II. Blood concentrations of lidocaine and metabolites during intravenous infusion. Acta Paediatr 81: 35\u201339","journal-title":"Acta Paediatr"},{"key":"136_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1378\/chest.81.5.644","volume":"81","author":"JJ Howard","year":"1982","unstructured":"Howard JJ, Mohsenifar Z, Simons SM (1982) Adult respiratory distress syndrome following administration of lidocaine. Chest 81: 644\u2013645","journal-title":"Chest"},{"key":"136_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO (1999)Xpose, an S-PLUS based model building aid for population analysis with NONMEM. Comp Meth Prog Biomed 58: 51\u201364","journal-title":"Comp Meth Prog Biomed"},{"key":"136_CR15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJM197412192912504","volume":"291","author":"KI Lie","year":"1974","unstructured":"Lie KI, Wellens HJ, van Capelle FJ, Durrer D (1974) Lidocaine in the prevention of primary ventricular fibrillation. A double-blind randomized study of 212 consecutive patients. N Engl J Med 291: 1324\u20131326","journal-title":"N Engl J Med"},{"key":"136_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clpt.2003.09.007","volume":"75","author":"R Orlando","year":"2004","unstructured":"Orlando R, Piccoli P, De Martin S, Padrini R, Floreani M, Palatini P (2004) Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. Clin Pharmacol Ther 75: 80\u201388","journal-title":"Clin Pharmacol Ther"},{"key":"136_CR17","first-page":"277","volume-title":"Neonatal seizures","author":"MF Radvanyi-Bouvet","year":"1990","unstructured":"Radvanyi-Bouvet MF, Torricelli A, Rey E, Bavoux F, Walti H (1990) Effects of lidocaine on seizures in the neonatal period: some electro-clinical aspects. In: Wasterlain CG, Vert P (eds) Neonatal seizures. Lippincott, Williams and Wilkins, Philadelphia, pp 277\u2013285"},{"key":"136_CR18","first-page":"193","volume":"18","author":"LM Resar","year":"1998","unstructured":"Resar LM, Helfaer MA (1998) Recurrent seizures in a neonate after lidocaine administration. J Perinatol 18:193\u2013195","journal-title":"J Perinatol"},{"key":"136_CR19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00007691-199007000-00003","volume":"12","author":"E Rey","year":"1990","unstructured":"Rey E, Radvanyi-Bouvet MF, Bodiou C, Richard MO, Torricelli A, Walti H, Olive G (1990) Intravenous lidocaine in the treatment of convulsions in the neonatal period: monitoring plasma levels. Ther Drug Monit 12:316\u2013320","journal-title":"Ther Drug Monit"},{"key":"136_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3476(82)80088-7","volume":"101","author":"P Rothstein","year":"1982","unstructured":"Rothstein P, Dornbusch J, Shaywitz BA (1982) Prolonged seizures associated with the use of viscous lidocaine. J Pediatr 101: 461\u2013463","journal-title":"J Pediatr"},{"key":"136_CR21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00431-004-1513-y","volume":"163","author":"LG Rooij Van","year":"2004","unstructured":"Van Rooij LG, Toet MC, Rademaker KM, Groenendaal F, de Vries LS (2004) Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment. Eur J Pediatr 163: 637\u2013641","journal-title":"Eur J Pediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-006-0136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-006-0136-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-006-0136-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:25:47Z","timestamp":1559082347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-006-0136-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,12]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["136"],"URL":"https:\/\/doi.org\/10.1007\/s00431-006-0136-x","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,12]]}}}